Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma
Clinical trial NCT03347617 · TERMINATED
Trial details
- NCT number
- NCT03347617
- Sponsor
- OHSU Knight Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-20
- Primary completion
- 2023-12-31
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.